APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nausea Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nausea Medicine Market Analysis and Forecast 2026-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchNausea Medicine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Nausea Medicine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Nausea Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nausea Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nausea Medicine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Nausea Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nausea Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nausea Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nausea Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nausea Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nausea Medicine include Sanofi, Merck, Roche, Pfizer, GlaxoSmithKline, TESARO and ANI Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nausea Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nausea Medicine, also provides the sales of main regions and countries. Of the upcoming market potential for Nausea Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nausea Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nausea Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nausea Medicine sales, projected growth trends, production technology, application and end-user industry.

Nausea Medicine Segment by Company

Sanofi

Merck

Roche

Pfizer

GlaxoSmithKline

TESARO

ANI Pharmaceuticals

Nausea Medicine Segment by Type

Antagonists

Antacids

Steroids

Others

Nausea Medicine Segment by Application

Pharmaceutical Companies

Clinics

Hospital

Nausea Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nausea Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nausea Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nausea Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nausea Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nausea Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nausea Medicine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nausea Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Antagonists Major Manufacturers Table 3. Antacids Major Manufacturers Table 4. Steroids Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Nausea Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Companies Major Manufacturers Table 8. Clinics Major Manufacturers Table 9. Hospital Major Manufacturers Table 10. Nausea Medicine Industry Trends Table 11. Nausea Medicine Industry Drivers Table 12. Nausea Medicine Industry Opportunities and Challenges Table 13. Nausea Medicine Industry Restraints Table 14. Global Nausea Medicine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Nausea Medicine Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Nausea Medicine Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Nausea Medicine Revenue Market Share by Region (2021-2026) Table 18. Global Nausea Medicine Revenue Market Share by Region (2027-2032) Table 19. Global Nausea Medicine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nausea Medicine Sales by Region (2021-2026) & (K Units) Table 21. Global Nausea Medicine Sales by Region (2027-2032) & (K Units) Table 22. Global Nausea Medicine Sales Market Share by Region (2021-2026) Table 23. Global Nausea Medicine Sales Market Share by Region (2027-2032) Table 24. Global Nausea Medicine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Nausea Medicine Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Nausea Medicine Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Nausea Medicine Sales Market Share by Manufacturers (2021-2026) Table 28. Global Nausea Medicine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Nausea Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Nausea Medicine Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Nausea Medicine Manufacturers, Product Type & Application Table 32. Global Nausea Medicine Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Nausea Medicine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Nausea Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Nausea Medicine Revenue Market Share by Type (2021-2026) Table 39. Global Nausea Medicine Revenue Market Share by Type (2027-2032) Table 40. Global Nausea Medicine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 42. Global Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 43. Global Nausea Medicine Sales Market Share by Type (2021-2026) Table 44. Global Nausea Medicine Sales Market Share by Type (2027-2032) Table 45. Global Nausea Medicine Price by Type (2021-2026) & (US$/Unit) Table 46. Global Nausea Medicine Price by Type (2027-2032) & (US$/Unit) Table 47. Global Nausea Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Nausea Medicine Revenue Market Share by Application (2021-2026) Table 51. Global Nausea Medicine Revenue Market Share by Application (2027-2032) Table 52. Global Nausea Medicine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 54. Global Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 55. Global Nausea Medicine Sales Market Share by Application (2021-2026) Table 56. Global Nausea Medicine Sales Market Share by Application (2027-2032) Table 57. Global Nausea Medicine Price by Application (2021-2026) & (US$/Unit) Table 58. Global Nausea Medicine Price by Application (2027-2032) & (US$/Unit) Table 59. Sanofi Company Information Table 60. Sanofi Business Overview Table 61. Sanofi Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Sanofi Nausea Medicine Product Portfolio Table 63. Sanofi Recent Development Table 64. Merck Company Information Table 65. Merck Business Overview Table 66. Merck Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Merck Nausea Medicine Product Portfolio Table 68. Merck Recent Development Table 69. Roche Company Information Table 70. Roche Business Overview Table 71. Roche Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Roche Nausea Medicine Product Portfolio Table 73. Roche Recent Development Table 74. Pfizer Company Information Table 75. Pfizer Business Overview Table 76. Pfizer Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Pfizer Nausea Medicine Product Portfolio Table 78. Pfizer Recent Development Table 79. GlaxoSmithKline Company Information Table 80. GlaxoSmithKline Business Overview Table 81. GlaxoSmithKline Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. GlaxoSmithKline Nausea Medicine Product Portfolio Table 83. GlaxoSmithKline Recent Development Table 84. TESARO Company Information Table 85. TESARO Business Overview Table 86. TESARO Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. TESARO Nausea Medicine Product Portfolio Table 88. TESARO Recent Development Table 89. ANI Pharmaceuticals Company Information Table 90. ANI Pharmaceuticals Business Overview Table 91. ANI Pharmaceuticals Nausea Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. ANI Pharmaceuticals Nausea Medicine Product Portfolio Table 93. ANI Pharmaceuticals Recent Development Table 94. North America Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 97. North America Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 98. North America Nausea Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 99. North America Nausea Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 100. North America Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 101. North America Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 102. North America Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 103. North America Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 104. North America Nausea Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 105. North America Nausea Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 106. North America Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Nausea Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 108. North America Nausea Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 109. North America Nausea Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 110. North America Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 111. North America Nausea Medicine Sales by Country (2027-2032) & (K Units) Table 112. North America Nausea Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 113. North America Nausea Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 114. United States Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 115. Canada Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 116. Europe Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 119. Europe Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 120. Europe Nausea Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 121. Europe Nausea Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 122. Europe Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 123. Europe Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 124. Europe Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 125. Europe Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 126. Europe Nausea Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 127. Europe Nausea Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 128. Europe Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Europe Nausea Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 130. Europe Nausea Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 131. Europe Nausea Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 132. Europe Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 133. Europe Nausea Medicine Sales by Country (2027-2032) & (K Units) Table 134. Europe Nausea Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 135. Europe Nausea Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 136. Germany Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 137. France Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 138. U.K. Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 139. Italy Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 141. Nordic Countries Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 142. China Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 143. China Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 144. China Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 145. China Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 146. China Nausea Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 147. China Nausea Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 148. China Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 149. China Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 150. China Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 151. China Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 152. China Nausea Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 153. China Nausea Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 154. Asia Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 157. Asia Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 158. Asia Nausea Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Asia Nausea Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Asia Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 163. Asia Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 164. Asia Nausea Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Asia Nausea Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Nausea Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Asia Nausea Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Asia Nausea Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 170. Asia Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 171. Asia Nausea Medicine Sales by Country (2027-2032) & (K Units) Table 172. Asia Nausea Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Asia Nausea Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Japan Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 175. South Korea Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 176. India Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 177. Australia Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 178. China Taiwan Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 179. Southeast Asia Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 180. SAMEA Nausea Medicine Revenue by Type (2021-2026) & (US$ Million) Table 181. SAMEA Nausea Medicine Revenue by Type (2027-2032) & (US$ Million) Table 182. SAMEA Nausea Medicine Sales by Type (2021-2026) & (K Units) Table 183. SAMEA Nausea Medicine Sales by Type (2027-2032) & (K Units) Table 184. SAMEA Nausea Medicine Sales Price by Type (2021-2026) & (US$/Unit) Table 185. SAMEA Nausea Medicine Sales Price by Type (2027-2032) & (US$/Unit) Table 186. SAMEA Nausea Medicine Revenue by Application (2021-2026) & (US$ Million) Table 187. SAMEA Nausea Medicine Revenue by Application (2027-2032) & (US$ Million) Table 188. SAMEA Nausea Medicine Sales by Application (2021-2026) & (K Units) Table 189. SAMEA Nausea Medicine Sales by Application (2027-2032) & (K Units) Table 190. SAMEA Nausea Medicine Sales Price by Application (2021-2026) & (US$/Unit) Table 191. SAMEA Nausea Medicine Sales Price by Application (2027-2032) & (US$/Unit) Table 192. SAMEA Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. SAMEA Nausea Medicine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. SAMEA Nausea Medicine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. SAMEA Nausea Medicine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 196. SAMEA Nausea Medicine Sales by Country (2021-2026) & (K Units) Table 197. SAMEA Nausea Medicine Sales by Country (2027-2032) & (K Units) Table 198. SAMEA Nausea Medicine Sales Price by Country (2021-2026) & (US$/Unit) Table 199. SAMEA Nausea Medicine Sales Price by Country (2027-2032) & (US$/Unit) Table 200. Brazil Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 201. Argentina Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 202. Chile Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 203. Colombia Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 204. Peru Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 205. Saudi Arabia Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 206. Israel Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 207. UAE Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 208. Turkey Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 209. Iran Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 210. Egypt Nausea Medicine Revenue (2021-2032) & (US$ Million) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Nausea Medicine Distributors List Table 214. Nausea Medicine Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Nausea Medicine Image Figure 2. Global Nausea Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nausea Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Antagonists Image Figure 5. Antacids Image Figure 6. Steroids Image Figure 7. Others Image Figure 8. Global Nausea Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nausea Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Companies Image Figure 11. Clinics Image Figure 12. Hospital Image Figure 13. Global Nausea Medicine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Nausea Medicine Revenue (2021-2032) & (US$ Million) Figure 15. Global Nausea Medicine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Nausea Medicine Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Nausea Medicine Revenue Market Share by Region (2021-2032) Figure 18. Global Nausea Medicine Sales (2021-2032) & (K Units) Figure 19. Global Nausea Medicine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Nausea Medicine Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Nausea Medicine Sales YoY (2021-2032) & (K Units) Figure 22. Europe Nausea Medicine Sales YoY (2021-2032) & (K Units) Figure 23. China Nausea Medicine Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Nausea Medicine Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Nausea Medicine Sales YoY (2021-2032) & (K Units) Figure 26. Global Nausea Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Nausea Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Nausea Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Nausea Medicine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Nausea Medicine Revenue Market Share by Type (2021-2032) Figure 32. Global Nausea Medicine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Nausea Medicine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Nausea Medicine Sales Market Share by Type (2021-2032) Figure 35. Global Nausea Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Nausea Medicine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Nausea Medicine Revenue Market Share by Application (2021-2032) Figure 38. Global Nausea Medicine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Nausea Medicine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Nausea Medicine Sales Market Share by Application (2021-2032) Figure 41. North America Nausea Medicine Revenue Share by Type (2021-2032) Figure 42. North America Nausea Medicine Sales Share by Type (2021-2032) Figure 43. North America Nausea Medicine Revenue Share by Application (2021-2032) Figure 44. North America Nausea Medicine Sales Share by Application (2021-2032) Figure 45. North America Nausea Medicine Revenue Share by Country (2021-2032) Figure 46. North America Nausea Medicine Sales Share by Country (2021-2032) Figure 47. Europe Nausea Medicine Revenue Share by Type (2021-2032) Figure 48. Europe Nausea Medicine Sales Share by Type (2021-2032) Figure 49. Europe Nausea Medicine Revenue Share by Application (2021-2032) Figure 50. Europe Nausea Medicine Sales Share by Application (2021-2032) Figure 51. Europe Nausea Medicine Revenue Share by Country (2021-2032) Figure 52. Europe Nausea Medicine Sales Share by Country (2021-2032) Figure 53. China Nausea Medicine Revenue Share by Type (2021-2032) Figure 54. China Nausea Medicine Sales Share by Type (2021-2032) Figure 55. China Nausea Medicine Revenue Share by Application (2021-2032) Figure 56. China Nausea Medicine Sales Share by Application (2021-2032) Figure 57. Asia Nausea Medicine Revenue Share by Type (2021-2032) Figure 58. Asia Nausea Medicine Sales Share by Type (2021-2032) Figure 59. Asia Nausea Medicine Revenue Share by Application (2021-2032) Figure 60. Asia Nausea Medicine Sales Share by Application (2021-2032) Figure 61. Asia Nausea Medicine Revenue Share by Country (2021-2032) Figure 62. Asia Nausea Medicine Sales Share by Country (2021-2032) Figure 63. SAMEA Nausea Medicine Revenue Share by Type (2021-2032) Figure 64. SAMEA Nausea Medicine Sales Share by Type (2021-2032) Figure 65. SAMEA Nausea Medicine Revenue Share by Application (2021-2032) Figure 66. SAMEA Nausea Medicine Sales Share by Application (2021-2032) Figure 67. SAMEA Nausea Medicine Revenue Share by Country (2021-2032) Figure 68. SAMEA Nausea Medicine Sales Share by Country (2021-2032) Figure 69. Nausea Medicine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Nausea Medicine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Antagonists
  • Antacids
  • Steroids
  • Others
Applications
  • Pharmaceutical Companies
  • Clinics
  • Hospital
Companies covered
  • Sanofi
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • TESARO
  • ANI Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nausea Medicine Market by Type
  3. 1.2.1 Global Nausea Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Antagonists
  5. 1.2.3 Antacids
  6. 1.2.4 Steroids
  7. 1.2.5 Others
  8. 1.3 Nausea Medicine Market by Application
  9. 1.3.1 Global Nausea Medicine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Companies
  11. 1.3.3 Clinics
  12. 1.3.4 Hospital
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Nausea Medicine Market Dynamics
  1. 2.1 Nausea Medicine Industry Trends
  2. 2.2 Nausea Medicine Industry Drivers
  3. 2.3 Nausea Medicine Industry Opportunities and Challenges
  4. 2.4 Nausea Medicine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nausea Medicine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nausea Medicine Revenue by Region
  3. 3.2.1 Global Nausea Medicine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nausea Medicine Revenue by Region (2021-2026)
  5. 3.2.3 Global Nausea Medicine Revenue by Region (2027-2032)
  6. 3.2.4 Global Nausea Medicine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nausea Medicine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nausea Medicine Sales by Region
  9. 3.4.1 Global Nausea Medicine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nausea Medicine Sales by Region (2021-2026)
  11. 3.4.3 Global Nausea Medicine Sales by Region (2027-2032)
  12. 3.4.4 Global Nausea Medicine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nausea Medicine Revenue by Manufacturers
  2. 4.1.1 Global Nausea Medicine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nausea Medicine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nausea Medicine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nausea Medicine Sales by Manufacturers
  6. 4.2.1 Global Nausea Medicine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nausea Medicine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nausea Medicine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nausea Medicine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nausea Medicine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nausea Medicine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nausea Medicine Manufacturers, Product Type & Application
  13. 4.7 Global Nausea Medicine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nausea Medicine Market CR5 and HHI
  16. 4.8.2 2025 Nausea Medicine Tier 1, Tier 2, and Tier 3
5 Nausea Medicine Market by Type
  1. 5.1 Global Nausea Medicine Revenue by Type
  2. 5.1.1 Global Nausea Medicine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nausea Medicine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nausea Medicine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nausea Medicine Sales by Type
  6. 5.2.1 Global Nausea Medicine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nausea Medicine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Nausea Medicine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nausea Medicine Price by Type
6 Nausea Medicine Market by Application
  1. 6.1 Global Nausea Medicine Revenue by Application
  2. 6.1.1 Global Nausea Medicine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nausea Medicine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nausea Medicine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nausea Medicine Sales by Application
  6. 6.2.1 Global Nausea Medicine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nausea Medicine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Nausea Medicine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nausea Medicine Price by Application
7 Company Profiles
  1. 7.1 Sanofi
  2. 7.1.1 Sanofi Company Information
  3. 7.1.2 Sanofi Business Overview
  4. 7.1.3 Sanofi Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sanofi Nausea Medicine Product Portfolio
  6. 7.1.5 Sanofi Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck Nausea Medicine Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Roche Nausea Medicine Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Pfizer
  20. 7.4.1 Pfizer Company Information
  21. 7.4.2 Pfizer Business Overview
  22. 7.4.3 Pfizer Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Nausea Medicine Product Portfolio
  24. 7.4.5 Pfizer Recent Developments
  25. 7.5 GlaxoSmithKline
  26. 7.5.1 GlaxoSmithKline Company Information
  27. 7.5.2 GlaxoSmithKline Business Overview
  28. 7.5.3 GlaxoSmithKline Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GlaxoSmithKline Nausea Medicine Product Portfolio
  30. 7.5.5 GlaxoSmithKline Recent Developments
  31. 7.6 TESARO
  32. 7.6.1 TESARO Company Information
  33. 7.6.2 TESARO Business Overview
  34. 7.6.3 TESARO Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 TESARO Nausea Medicine Product Portfolio
  36. 7.6.5 TESARO Recent Developments
  37. 7.7 ANI Pharmaceuticals
  38. 7.7.1 ANI Pharmaceuticals Company Information
  39. 7.7.2 ANI Pharmaceuticals Business Overview
  40. 7.7.3 ANI Pharmaceuticals Nausea Medicine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 ANI Pharmaceuticals Nausea Medicine Product Portfolio
  42. 7.7.5 ANI Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Nausea Medicine Market Size by Type
  2. 8.1.1 North America Nausea Medicine Revenue by Type (2021-2032)
  3. 8.1.2 North America Nausea Medicine Sales by Type (2021-2032)
  4. 8.1.3 North America Nausea Medicine Price by Type (2021-2032)
  5. 8.2 North America Nausea Medicine Market Size by Application
  6. 8.2.1 North America Nausea Medicine Revenue by Application (2021-2032)
  7. 8.2.2 North America Nausea Medicine Sales by Application (2021-2032)
  8. 8.2.3 North America Nausea Medicine Price by Application (2021-2032)
  9. 8.3 North America Nausea Medicine Market Size by Country
  10. 8.3.1 North America Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nausea Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nausea Medicine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nausea Medicine Market Size by Type
  2. 9.1.1 Europe Nausea Medicine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nausea Medicine Sales by Type (2021-2032)
  4. 9.1.3 Europe Nausea Medicine Price by Type (2021-2032)
  5. 9.2 Europe Nausea Medicine Market Size by Application
  6. 9.2.1 Europe Nausea Medicine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nausea Medicine Sales by Application (2021-2032)
  8. 9.2.3 Europe Nausea Medicine Price by Application (2021-2032)
  9. 9.3 Europe Nausea Medicine Market Size by Country
  10. 9.3.1 Europe Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nausea Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nausea Medicine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Nausea Medicine Market Size by Type
  2. 10.1.1 China Nausea Medicine Revenue by Type (2021-2032)
  3. 10.1.2 China Nausea Medicine Sales by Type (2021-2032)
  4. 10.1.3 China Nausea Medicine Price by Type (2021-2032)
  5. 10.2 China Nausea Medicine Market Size by Application
  6. 10.2.1 China Nausea Medicine Revenue by Application (2021-2032)
  7. 10.2.2 China Nausea Medicine Sales by Application (2021-2032)
  8. 10.2.3 China Nausea Medicine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nausea Medicine Market Size by Type
  2. 11.1.1 Asia Nausea Medicine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nausea Medicine Sales by Type (2021-2032)
  4. 11.1.3 Asia Nausea Medicine Price by Type (2021-2032)
  5. 11.2 Asia Nausea Medicine Market Size by Application
  6. 11.2.1 Asia Nausea Medicine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nausea Medicine Sales by Application (2021-2032)
  8. 11.2.3 Asia Nausea Medicine Price by Application (2021-2032)
  9. 11.3 Asia Nausea Medicine Market Size by Country
  10. 11.3.1 Asia Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nausea Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nausea Medicine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nausea Medicine Market Size by Type
  2. 12.1.1 SAMEA Nausea Medicine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nausea Medicine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nausea Medicine Price by Type (2021-2032)
  5. 12.2 SAMEA Nausea Medicine Market Size by Application
  6. 12.2.1 SAMEA Nausea Medicine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nausea Medicine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nausea Medicine Price by Application (2021-2032)
  9. 12.3 SAMEA Nausea Medicine Market Size by Country
  10. 12.3.1 SAMEA Nausea Medicine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nausea Medicine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nausea Medicine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nausea Medicine Value Chain Analysis
  2. 13.1.1 Nausea Medicine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nausea Medicine Production Mode & Process
  6. 13.2 Nausea Medicine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nausea Medicine Distributors
  9. 13.2.3 Nausea Medicine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst